{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:52:01Z","timestamp":1792900321584,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Natural Science Foundation of Hubei Province of China","award":["2024AFB818"],"award-info":[{"award-number":["2024AFB818"]}]},{"name":"the Cultivating Project for Young Scholar at Hubei University of Medicine","award":["2020QDJZR013"],"award-info":[{"award-number":["2020QDJZR013"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-025-05499-9","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T03:10:13Z","timestamp":1763608213000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Metformin Inhibits Microglial Activation-Mediated Cuproptosis by Modulating the TLR4\/Myd88\/NF-\u03baB Signaling Pathway in Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"63","author":[{"given":"Hui","family":"Shang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanpeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"issue":"10291","key":"5499_CR1","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C (2021) Parkinson\u2019s disease. Lancet 397(10291):2284\u20132303. https:\/\/doi.org\/10.1016\/S0140-6736(21)00218-X","journal-title":"Lancet"},{"issue":"5","key":"5499_CR2","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa E, Garrido A, Scholz SW, Poewe W (2021) Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol 20(5):385\u2013397. https:\/\/doi.org\/10.1016\/S1474-4422(21)00030-2","journal-title":"Lancet Neurol"},{"issue":"7","key":"5499_CR3","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S1474-4422(21)00061-2","volume":"20","author":"N Vijiaratnam","year":"2021","unstructured":"Vijiaratnam N, Simuni T, Bandmann O, Morris HR, Foltynie T (2021) Progress towards therapies for disease modification in Parkinson\u2019s disease. Lancet Neurol 20(7):559\u2013572. https:\/\/doi.org\/10.1016\/S1474-4422(21)00061-2","journal-title":"Lancet Neurol"},{"key":"5499_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00191","volume":"11","author":"Z Lv","year":"2020","unstructured":"Lv Z, Guo Y (2020) Metformin and its benefits for various diseases. Front Endocrinol 11:191. https:\/\/doi.org\/10.3389\/fendo.2020.00191","journal-title":"Front Endocrinol"},{"key":"5499_CR5","doi-asserted-by":"publisher","first-page":"170","DOI":"10.5604\/01.3001.0010.3801","volume":"71","author":"M Podhorecka","year":"2017","unstructured":"Podhorecka M, Ibanez B, Dmoszy\u0144ska A (2017) Metformin - its potential anti-cancer and anti-aging effects. Postepy Hig Med Dosw 71:170\u2013175. https:\/\/doi.org\/10.5604\/01.3001.0010.3801","journal-title":"Postepy Hig Med Dosw"},{"key":"5499_CR6","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3389\/fendo.2018.00400","volume":"9","author":"C Rotermund","year":"2018","unstructured":"Rotermund C, Machetanz G, Fitzgerald JC (2018) The therapeutic potential of metformin in neurodegenerative diseases. Front Endocrinol 9:400. https:\/\/doi.org\/10.3389\/fendo.2018.00400","journal-title":"Front Endocrinol"},{"issue":"1","key":"5499_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010398","volume":"23","author":"F Agostini","year":"2021","unstructured":"Agostini F, Masato A, Bubacco L, Bisaglia M (2021) Metformin repurposing for Parkinson disease therapy: opportunities and challenges. Int J Mol Sci 23(1):398. https:\/\/doi.org\/10.3390\/ijms23010398","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5499_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/14737175.2021.1847645","volume":"21","author":"S Demar\u00e9","year":"2021","unstructured":"Demar\u00e9 S, Kothari A, Calcutt NA, Fernyhough P (2021) Metformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system. Expert Rev Neurother 21(1):45\u201363. https:\/\/doi.org\/10.1080\/14737175.2021.1847645","journal-title":"Expert Rev Neurother"},{"issue":"5","key":"5499_CR9","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1080\/15376516.2020.1741053","volume":"30","author":"DX Wang","year":"2020","unstructured":"Wang DX, Chen AD, Wang QJ, Xin YY, Yin J, Jing YH (2020) Protective effect of metformin against rotenone-induced parkinsonism in mice. Toxicol Mech Methods 30(5):350\u2013357. https:\/\/doi.org\/10.1080\/15376516.2020.1741053","journal-title":"Toxicol Mech Methods"},{"issue":"10","key":"5499_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.724","volume":"5","author":"Y Yang","year":"2024","unstructured":"Yang Y, Wu J, Wang L, Ji G, Dang Y (2024) Copper homeostasis and cuproptosis in health and disease. MedComm 5(10):e724. https:\/\/doi.org\/10.1002\/mco2.724","journal-title":"MedComm"},{"key":"5499_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.932676","volume":"14","author":"Y Lai","year":"2022","unstructured":"Lai Y, Lin C, Lin X, Wu L, Zhao Y, Lin F (2022) Identification and immunological characterization of cuproptosis-related molecular clusters in Alzheimer\u2019s disease. Front Aging Neurosci 14:932676. https:\/\/doi.org\/10.3389\/fnagi.2022.932676","journal-title":"Front Aging Neurosci"},{"issue":"7","key":"5499_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/cells12071012","volume":"12","author":"S Isik","year":"2023","unstructured":"Isik S, Kiyak BY, Akbayir R, Seyhali R, Arpaci T (2023) Microglia mediated neuroinflammation in Parkinson\u2019s disease. Cells 12(7):1012. https:\/\/doi.org\/10.3390\/cells12071012","journal-title":"Cells"},{"issue":"6","key":"5499_CR13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41582-020-0344-4","volume":"16","author":"EK Tan","year":"2020","unstructured":"Tan EK, Chao YX, West A, Chan LL, Poewe W, Jankovic J (2020) Parkinson disease and the immune system - associations, mechanisms and therapeutics. Nat Rev Neurol 16(6):303\u2013318. https:\/\/doi.org\/10.1038\/s41582-020-0344-4","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"5499_CR14","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1007\/s12035-023-03713-0","volume":"61","author":"P Huang","year":"2024","unstructured":"Huang P, Zhang Z, Zhang P, Feng J, Xie J, Zheng Y, LiangX ZhuB et al (2024) TREM2 deficiency aggravates NLRP3 inflammasome activation and pyroptosis in MPTP-induced Parkinson\u2019s disease mice and LPS-induced BV2 cells. Mol Neurobiol 61(5):2590\u20132605. https:\/\/doi.org\/10.1007\/s12035-023-03713-0","journal-title":"Mol Neurobiol"},{"issue":"2","key":"5499_CR15","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.expneurol.2008.12.007","volume":"216","author":"S Ji","year":"2009","unstructured":"Ji S, Kronenberg G, Balkaya M, F\u00e4rber K, Gertz K, Kettenmann H, Endres M (2009) Acute neuroprotection by pioglitazone after mild brain ischemia without effect on long-term outcome. Exp Neurol 216(2):321\u2013328. https:\/\/doi.org\/10.1016\/j.expneurol.2008.12.007","journal-title":"Exp Neurol"},{"issue":"1","key":"5499_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/s0165-0270(96)02211-x","volume":"73","author":"K Matsuura","year":"1997","unstructured":"Matsuura K, Kabuto H, Makino H, Ogawa N (1997) Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion. J Neurosci Methods 73(1):45\u201348. https:\/\/doi.org\/10.1016\/s0165-0270(96)02211-x","journal-title":"J Neurosci Methods"},{"issue":"2","key":"5499_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.14573\/altex.2009.2.83","volume":"26","author":"A Henn","year":"2009","unstructured":"Henn A, Lund S, Hedtj\u00e4rn M, Schrattenholz A, P\u00f6rzgen P, Leist M (2009) The suitability of BV2 cells as alternative modelsystem for primary microglia cultures or for animal experiments examining brain inflammation. ALTEX 26(2):83\u201394. https:\/\/doi.org\/10.14573\/altex.2009.2.83","journal-title":"ALTEX"},{"issue":"1","key":"5499_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0300-483x(88)90169-2","volume":"49","author":"TP Singer","year":"1988","unstructured":"Singer TP, Ramsay RR, McKeown K, Trevor A, Castagnoli NE Jr (1988) Mechanism of the neurotoxicity of 1-methyl-4-phenylpyridinium (MPP+), the toxic bioactivation product of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Toxicology 49(1):17\u201323. https:\/\/doi.org\/10.1016\/0300-483x(88)90169-2","journal-title":"Toxicology"},{"key":"5499_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2020.111644","volume":"144","author":"X Li","year":"2020","unstructured":"Li X, Zhang J, Zhang X, Dong M (2020) Puerarin suppresses MPP+\/MPTP-induced oxidative stress through an Nrf2-dependent mechanism. Food Chem Toxicol 144:111644. https:\/\/doi.org\/10.1016\/j.fct.2020.111644","journal-title":"Food Chem Toxicol"},{"issue":"6","key":"5499_CR20","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/jnc.14675","volume":"149","author":"PR Dunkley","year":"2019","unstructured":"Dunkley PR, Dickson PW (2019) Tyrosine hydroxylase phosphorylation in vivo. J Neurochem 149(6):706\u2013728. https:\/\/doi.org\/10.1111\/jnc.14675","journal-title":"J Neurochem"},{"issue":"7794","key":"5499_CR21","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","volume":"578","author":"M Shahnawaz","year":"2020","unstructured":"Shahnawaz M, Mukherjee A, Pritzkow S, Mendez N, Rabadia P, Liu X, Hu B, Schmeichel A et al (2020) Discriminating \u03b1-synuclein strains in Parkinson\u2019s disease and multiple system atrophy. Nature 578(7794):273\u2013277. https:\/\/doi.org\/10.1038\/s41586-020-1984-7","journal-title":"Nature"},{"key":"5499_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102214","volume":"95","author":"M Huang","year":"2024","unstructured":"Huang M, Zhang Y, Liu X (2024) The mechanism of cuproptosis in Parkinson\u2019s disease. Ageing Res Rev 95:102214. https:\/\/doi.org\/10.1016\/j.arr.2024.102214","journal-title":"Ageing Res Rev"},{"issue":"8","key":"5499_CR23","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/s41589-023-01383-6","volume":"19","author":"CJ Chang","year":"2023","unstructured":"Chang CJ, Brady DC (2023) Capturing copper to inhibit inflammation. Nat Chem Biol 19(8):937\u2013939. https:\/\/doi.org\/10.1038\/s41589-023-01383-6","journal-title":"Nat Chem Biol"},{"issue":"1","key":"5499_CR24","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1038\/s41467-020-16544-7","volume":"11","author":"T Liu","year":"2020","unstructured":"Liu T, Xiao B, Xiang F, Tan J, Chen Z, Zhang X, Wu C, Mao Z et al (2020) Ultrasmall copper-based nanoparticles for reactive oxygen species scavenging and alleviation of inflammation related diseases. Nat Commun 11(1):2788. https:\/\/doi.org\/10.1038\/s41467-020-16544-7","journal-title":"Nat Commun"},{"key":"5499_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2023.103850","volume":"125","author":"I Ercan","year":"2023","unstructured":"Ercan I, Micili SC, Soy S, Engur D, Tufekci KU, Kumral A, Genc S (2023) Bilirubin induces microglial NLRP3 inflammasome activation in vitro and in vivo. Mol Cell Neurosci 125:103850. https:\/\/doi.org\/10.1016\/j.mcn.2023.103850","journal-title":"Mol Cell Neurosci"},{"issue":"1","key":"5499_CR26","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12974-019-1538-9","volume":"16","author":"M Zusso","year":"2019","unstructured":"Zusso M, Lunardi V, Franceschini D, Pagetta A, Lo R, Stifani S, Frigo AC et al (2019) Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4\/NF-kB pathway. J Neuroinflammation 16(1):148. https:\/\/doi.org\/10.1186\/s12974-019-1538-9","journal-title":"J Neuroinflammation"},{"issue":"4","key":"5499_CR27","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s00018-020-03656-y","volume":"78","author":"A Ciesielska","year":"2021","unstructured":"Ciesielska A, Matyjek M, Kwiatkowska K (2021) TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling. Cell Mol Life Sci 78(4):1233\u20131261. https:\/\/doi.org\/10.1007\/s00018-020-03656-y","journal-title":"Cell Mol Life Sci"},{"key":"5499_CR28","doi-asserted-by":"publisher","first-page":"112361","DOI":"10.1016\/j.jep.2019.112361","volume":"248","author":"N Hu","year":"2020","unstructured":"Hu N, Wang C, Dai X, Zhou M, Gong L, Yu L, Peng C, Li Y (2020) Phillygenin inhibits LPS-induced activation and inflammation of LX2 cells by TLR4\/MyD88\/NF-\u03baB signaling pathway. J Ethnopharmacol 248:112361. https:\/\/doi.org\/10.1016\/j.jep.2019.112361","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"5499_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12974-023-02721-0","volume":"20","author":"Y Wang","year":"2023","unstructured":"Wang Y, Sadike D, Huang B, Li P, Wu Q, Jiang N, Fang Y, Song G et al (2023) Regulatory T cells alleviate myelin loss and cognitive dysfunction by regulating neuroinflammation and microglial pyroptosis via TLR4\/MyD88\/NF-\u03baB pathway in LPC-induced demyelination. J Neuroinflammation 20(1):41. https:\/\/doi.org\/10.1186\/s12974-023-02721-0","journal-title":"J Neuroinflammation"},{"issue":"42","key":"5499_CR30","doi-asserted-by":"publisher","first-page":"26438","DOI":"10.1073\/pnas.2009838117","volume":"117","author":"DE Mor","year":"2020","unstructured":"Mor DE, Sohrabi S, Kaletsky R, Keyes W, Tartici A, Kalia V, Miller GW, Murphy CT (2020) Metformin rescues Parkinson\u2019s disease phenotypes caused by hyperactive mitochondria. Proc Natl Acad Sci USA 117(42):26438\u201326447. https:\/\/doi.org\/10.1073\/pnas.2009838117","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"5499_CR31","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41422-022-00653-7","volume":"32","author":"D Tang","year":"2022","unstructured":"Tang D, Chen X, Kroemer G (2022) Cuproptosis: a copper-triggered modality of mitochondrial cell death. Cell Res 32(5):417\u2013418. https:\/\/doi.org\/10.1038\/s41422-022-00653-7","journal-title":"Cell Res"},{"issue":"1","key":"5499_CR32","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13045-024-01589-8","volume":"17","author":"C Zhang","year":"2024","unstructured":"Zhang C, Huang T, Li L (2024) Targeting cuproptosis for cancer therapy: mechanistic insights and clinical perspectives. J Hematol Oncol 17(1):68. https:\/\/doi.org\/10.1186\/s13045-024-01589-8","journal-title":"J Hematol Oncol"},{"key":"5499_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.116115","volume":"171","author":"N Liu","year":"2024","unstructured":"Liu N, Chen M (2024) Crosstalk between ferroptosis and cuproptosis: from mechanism to potential clinical application. Biomed Pharmacother 171:116115. https:\/\/doi.org\/10.1016\/j.biopha.2023.116115","journal-title":"Biomed Pharmacother"},{"issue":"18","key":"5499_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/cells11182908","volume":"11","author":"B Ara\u00fajo","year":"2022","unstructured":"Ara\u00fajo B, Caridade-Silva R, Soares-Guedes C, Martins-Macedo J, Gomes ED, Monteiro S, Teixeira FG (2022) Neuroinflammation and Parkinson\u2019s disease-from neurodegeneration to therapeutic opportunities. Cells 11(18):2908. https:\/\/doi.org\/10.3390\/cells11182908","journal-title":"Cells"},{"issue":"9","key":"5499_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094676","volume":"22","author":"K Badanjak","year":"2021","unstructured":"Badanjak K, Fixemer S, Smaji\u0107 S, Skupin A, Gr\u00fcnewald A (2021) The contribution of microglia to neuroinflammation in Parkinson\u2019s disease. Int J Mol Sci 22(9):4676. https:\/\/doi.org\/10.3390\/ijms22094676","journal-title":"Int J Mol Sci"},{"issue":"8","key":"5499_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23084148","volume":"23","author":"TW Liu","year":"2022","unstructured":"Liu TW, Chen CM, Chang KH (2022) Biomarker of neuroinflammation in Parkinson\u2019s disease. Int J Mol Sci 23(8):4148. https:\/\/doi.org\/10.3390\/ijms23084148","journal-title":"Int J Mol Sci"},{"issue":"24","key":"5499_CR37","doi-asserted-by":"publisher","first-page":"13397","DOI":"10.3390\/ijms222413397","volume":"22","author":"K Wicherska-Paw\u0142owska","year":"2021","unstructured":"Wicherska-Paw\u0142owska K, Wr\u00f3bel T, Rybka J (2021) Toll-like receptors (TLRs), NOD-like receptors (NLRs), and RIG-I-like receptors (RLRs) in innate immunity. Int J Mol Sci 22(24):13397. https:\/\/doi.org\/10.3390\/ijms222413397","journal-title":"Int J Mol Sci"},{"issue":"9","key":"5499_CR38","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1016\/j.apsb.2021.03.020","volume":"11","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Li F, Ning J, Peng R, Shang J, Liu H, Shang M, Bao XQ et al (2021) Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4\/MyD88\/NF-\u03baB pathway through microbiota-gut-brain axis. Acta Pharm Sin B 11(9):2859\u20132879. https:\/\/doi.org\/10.1016\/j.apsb.2021.03.020","journal-title":"Acta Pharm Sin B"},{"key":"5499_CR39","doi-asserted-by":"publisher","first-page":"114917","DOI":"10.1016\/j.biopha.2023.114917","volume":"164","author":"MH ElSayed","year":"2023","unstructured":"ElSayed MH, Atif HM, Eladl MA, Elaidy SM, Helaly AMN, Hisham FA, Farag NE, Osman NMS et al (2023) Betanin improves motor function and alleviates experimental Parkinsonism via downregulation of TLR4\/MyD88\/NF-\u03baB pathway. Biomed Pharmacother 164:114917. https:\/\/doi.org\/10.1016\/j.biopha.2023.114917","journal-title":"Biomed Pharmacother"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05499-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05499-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05499-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T03:10:15Z","timestamp":1763608215000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05499-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5499"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05499-9","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"26 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study was approved by the Ethics Committee of Hubei University of Medicine on October 20, 2021 (approval No. 2021\u2013059), and conducted in strict accordance with international laws and National Institutes of Health policies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"95"}}